Clinical trial
Creatine to Augment Bioenergetics in Alzheimer's
NCT05383833 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Creatine to Augment Bioenergetics in Alzheimer's
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 12, 2022
- Completion date
- May 14, 2024
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease